3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
2
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Cancer Metastatic to Liver
1
Interventions
Capecitabine
9
Bevacizumab
8
tislelizumab
7
Oxaliplatin
7
Drug Therapy
7
pembrolizumab
6
Surgical Procedures, Operative
6
Standard of Care
6
Cisplatin
6
Radiotherapy
5
Laparoscopy
5
Fluorouracil
5
Docetaxel
5
Carboplatin
5
Radiosurgery
4
Leucovorin
4
Exercise
4
Epirubicin
4
Cyclophosphamide
4
toripalimab
3
pertuzumab
3
durvalumab
3
dalpiciclib
3
atezolizumab
3
anlotinib
3
Saline Solution
3
Rituximab
3
Prednisone
3
Population Groups
3
Observation
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Cholangiopancreatography, Endoscopic Retrograde
×
1 year
×
Clear all
NCT07191418
2026-03-06
Spearmint
Region Västerbotten
Phase NA
Not yet recruiting
178 enrolled